A biophysical comparison of human serum albumin to be glycated in vivo and in vitro

Journal of Medical Biochemistry

Volumn 30, Issue 1, 2011, Pages 5-10

  Sattarahmady, Naghmeh ^a   Moosavi Movahedi, Ali ^b   Habibi Rezaei, Mehran ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

arginine residue; diabetic individual; glycation; human serum albumin

Indexed keywords

1,2 DICARBONYL DERIVATIVE; 3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ARGININE; HUMAN SERUM ALBUMIN; SCHIFF BASE;

AFFINITY CHROMATOGRAPHY; ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE ANALYSIS; GLYCATION; HUMAN; HUMAN TISSUE; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SURFACE TENSION;

EID: 78649668281     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0026-7     Document Type: Article

References (27)

1. Khalifah RG, Baynes JW, Hudson BG. Ama do rins: novel post-Amadori inhibitors of advanced glycation reac tions. Biochem Biophys Res Commun 1999; 257: 251-8.
2. Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 2005; 38: 103-15.
3. Shaklai N, Garlick RL, Bunn H F. Nonenzymatic glycosylation of human serum albumin alters its confor mation and function. J Biol Chem 1984; 259 (6): 3812-7.
4. Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG. Modification of proteins In Vitro by physiological levels of glucose. J Biol Chem 2003; 278 (47): 46616-24.
5. Cussimanio BL, Booth AA, Todd P, Hudson BG, Khalifah RG. Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation. Biophys Chem 2003; 105: 43-755.
6. Trueb B, Holenstein CG, Fischer RW, Winterhalter KH. Nonenzymatic glycosylation of proteins. J Biol Chem 1980; 255 (14): 6714-20.
7. He XM, Carter DC. Atomic structure and che mi stry of human serum albumin. Nature 1992; 358: 209-15.
8. Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY. Three-dimen sional structure of human serum albumin. Science 1989; 244: 1195-8.
9. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999; 13: 233-43.
10. Iberg N, Fluckiger R. Nonenzymatic glyco sylation of albumin in vitro (Identification of multiple glycosylated sites). J Biol Chem 1986; 261: 13542-5.
11. Coussons PJ, Jacoby J, McKay A, Kelly SM, Price NC, Hunt J V. Glucose modification of human serum albumin: a structural study. Free Radical Biol Med 1997; 22: 1217-27.
12. Sharma SD, Pandey BN, Mishra K P, Sivakami S. Amadori product and AGE formation during nonenzymatic glycosylation of bovine serum albumin In Vitro. J Biochem Mol Biol Biophys 2002; 6 (4): 233-42.
13. Shaklai N, Garlick RL, Bunn H F. Nonenzymatic gly cosylation of human serum albumin alters its conformation and function. J Biol Chem 1984; 259 (6): 3812-7.
14. Mendez DM, Jensen RA, McElroy LA, Pena JM, Esquerra RM. The effect of non-enzymatic glycation on the unfolding of human serum albumin. Arch Biochem Biophys 2005; 444: 92-9.
15. Zoellner H, Hou YH, Hochgrebe T, Poljak A, Duncan MW, Golding J, Henderson T, Lynch G. Fluorometric and Mass Spectrometric Analysis of Nonenzymatic Glycosylated Albumin. Biochem Biophys Res Commun 2001; 284: 83-9.
16. Bouma B, Kroon-Batenburg LMJ, Wu Y P, Brunjes B, Posthuma G, Kranenburg O, Groot PG de, Voest EE, Gebbink MFBG. Glycation induces formation of amyloid cross-b structure in albumin. J Biol Chem 2003; 278: 41810-9.
17. Westwood ME, Thornalley PJ. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation end product-modi fied serum albumins. J Protein Chem 1995; 4: 359-72.
18. Biemel KM, Friedl DA, Lederer MO. Identi fi cation and quantification of major Maillard cross-links in human serum albumin and lens protein. J Biol Chem 2002; 277: 24907-15.
19. Sattarahmady N, Moosavi-Movahedi AA, Ahmad F, Hakimelahi GH, Habibi-Rezaei M, Saboury AA, Sheibani N. Formation of the Molten Globule-Like State during Prolonged Glycation of Human Serum Albumin. Biochim Biophys Acta 2007; 1770: 933-42.
20. Sattarahmady N, Khodagholi F, Moosavi-Movahedi AA, Heli H, Hakimelahi GH. Alginate as antiglycating agent for human serum albumin. Int J Biol Macromol 2007; 41: 180-4.
21. Sattarahmady N, Moosavi-Movahedi AA, Habibi-Rezaei M, Ahmadian S, Saboury AA, Heli H, Sheibani N. Detergency effect of nanofibrillar amyloid for mation on glycation of human serum albumin. Carbo hydrate Res 2008; 343: 2229-34.
22. Ma Z Y, Guan Y P, Liu HZ. Affinity adsorption of albumin on Cibacron Blue F3GA-coupled non-porous micrometer-sized magnetic polymer microspheres. React Funct Polym 2006; 66: 618-24.
23. Ledden DJ, Feldhoff RC, Chan SK. Charac te rization of fragments of human albumin purified by Cibacron Blue F3GA affinity chromatography. Biochem J 1982; 205: 331-7.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
25. Wilson C. Staining of proteins on gels: compa rison of dyes and procedures. Methods Enzymol 1983; 91: 236-47.
26. Schmitt A, Schmitt J, Münch G, Gasic-Milencovic J. Characterization of advanced glycation end products for bioche mical studies: side chain modifications and fluorescence characteristics. Anal Biochem 2005; 338: 201-15.
27. Stankov K. Genetic predisposition for type 1 diabetes mellitus The Role of endoplasmic reticulum stress in human disease etiopathogenesis. Journal od Medical Biochemistry 2010; 29: 139-49.